这种一直被忽略的疫苗可以挽救视力

2022-11-19 生物探索 生物探索

带状疱疹俗称“腰缠龙”,它是由水痘病毒引起的,它可以在人体内一直潜伏,水痘重新出现导致带状疱疹。

2018年4月,马思纯得了带状疱疹,发博称“头皮是疼的,脸上是痒的,淋巴是肿的。”虽然她的语气轻松,但得过的人都知道,带状疱疹发作起来的神经痛那真的要命,疼起来比分娩还痛!而且严重的会造成失明。其实接种带状疱疹疫苗可以有效避免病情的发生。2006年FDA批准了美国第一个带状疱疹疫苗—Zostavax。这项具有里程碑意义的研究于2005年发表在《新英格兰医学杂志》上,研究涉及38000名60岁及以上老年人(注:研究只包括60岁及以上人群,所以它只被批准用于该组),并且发现该疫苗将带状疱疹的发病率降低了51%!此外,带状疱疹疫苗是一种减毒活病毒,而减毒活疫苗是指病原体经过各种处理后,发生变异,毒性减弱,但仍保留其免疫原性。将其接种到身体内,不会引起疾病的发生,但病原体可在机体内生长繁殖,引发机体免疫反应,起到获得长期或终生保护的作用。因此减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。2011年,FDA将疫苗的接种范围扩大到50岁及以上人群。

关于带状疱疹

1什么是带状疱疹?

-带状疱疹俗称“腰缠龙”,它是由水痘病毒引起的,它可以在人体内一直潜伏,水痘重新出现导致带状疱疹。

-带状疱疹是一种持续数周的疼痛起泡皮肤病变。它具有引起带状疱疹后遗神经痛的并发症。对于带状疱疹后神经痛,在带状疱疹发作消退后疼痛仍在继续。这种痛苦可以持续很多年。

-97% 的成年人体内携带带状疱疹病毒。

-1/3的成年人有患带状疱疹的风险。

-带状疱疹的发病率和严重程度随着年龄的增长而增加。

2带状疱疹典型表现

-带状疱疹后神经痛引起的疼痛通常被描述为灼痛或刺痛。

-有许多治疗方法可以减轻疼痛,但通常很难完全控制。

-带状疱疹可能会在发作后的六个月内增加中风的风险。

3严重情况:眼部带状疱疹 

-眼部带状疱疹是带状疱疹涉及到眼睛的一种情况,它的发病率在带状疱疹病例中达到25%以上。眼部带状疱疹非常严重,会让面部留下疤痕并造成失明的风险。

-病毒侵犯三叉神经眼支,多见于老年人,疼痛剧烈,可累及角膜形成溃疡性角膜炎。系病毒侵犯三叉神经眼支,多见于老年人,疼痛剧烈,可累及角膜形成溃疡性角膜炎。眼部带状疱疹

疫苗将带状疱疹的发病率降低了51%,虽然预防率没有达到100%,但众所周知,带状疱疹对眼睛造成的危害极大,疫苗能达到的效果已经是里程碑式的突破,所以依然要鼓励50岁以上的中老年人去接种带状疱疹疫苗。

2017年,FDA批准了一种重组亚单位带状疱疹疫苗(Shingrix)。这次临床试验涉及超过15000名50岁及以上的参与者,并且该疫苗在所有年龄组中的有效性都超过96%。显而易见,预防率96%比起51%更是天花板级别的突破,而且Shingrix这种疫苗不是减毒活病毒,因此可用于免疫力低下的人群。

临床试验的结果在现实世界中并不总会重复出现,而且这些试验一般是针对带状疱疹而不是眼部带状疱疹。那么,这种新型带状疱疹疫苗可以预防眼部带状疱疹吗?

重组带状疱疹疫苗对眼部带状疱疹的有效性

研究的数据库自2018年至2019年的2年中涉及480 万人,研究人员发现重组带状疱疹疫苗对眼部带状疱疹的有效率为89%,对于现实生活中眼部带状疱疹的患病情况来说,这真是喜从天降的好消息,避免了很多视力问题、甚至是拯救了失明!然而,研究人员还发现,只有3.7%的患者接种了两剂有效剂量的疫苗(重组带状疱疹疫苗共2剂)。这也在意料之中。研究人员指出,在 FDA 批准带状疱疹疫苗后的近十年,也只有31%的60岁以上的老年人接种了原始的带状疱疹疫苗。

也许还有人不知道眼部带状疱疹的可怕程度。威尔斯眼科医院的合伙人Elisabeth Cohen博士曾公开表示,她迫不得已停止临床实践的原因之一正是因为她身患眼部带状疱疹从而导致视力急剧下降!Elisabeth Cohen博士现在正在纽约大学进行一项大型的多中心试验:抑制性抗病毒治疗对眼部带状疱疹的疗效。

据透露,国内已经很多个省份开放接种重组带状疱疹疫苗,共需要接种2针,两次需要间隔2-6月。多位专业专家呼吁:建议所有50岁或以上的中老年人都去接种带状疱疹疫苗,希望大家增强免疫力,远离带状疱疹。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-20 ms6000000721730121

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-20 仁术2021

    不错,学习了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-20 邝医生

    学习了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-19 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-19 13d0179fm99暂无昵称

    学习坚持分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-19 zwddoctor

    减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2101599, encodeId=06c9210159934, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a548298813, createdName=ms6000000721730121, createdTime=Sun Nov 20 09:07:20 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101591, encodeId=2bfb21015916b, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Nov 20 07:58:15 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101589, encodeId=2cde210158951, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220226/f73f0026212346d08cbefd29e427d3b5/87e7cfec87ac40d8ad99d344d98e9a32.jpg, createdBy=c38c6523737, createdName=邝医生, createdTime=Sun Nov 20 07:49:05 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101574, encodeId=9b6021015e46e, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Nov 19 23:47:50 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101573, encodeId=33a221015e350, content=学习坚持分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65724176436, createdName=13d0179fm99暂无昵称, createdTime=Sat Nov 19 23:33:18 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101565, encodeId=f700210156549, content=减毒活疫苗在大多数免疫功能低下的个体中是被禁用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a31581237, createdName=zwddoctor, createdTime=Sat Nov 19 22:51:30 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101551, encodeId=f36e2101551a9, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Nov 19 21:05:35 CST 2022, time=2022-11-19, status=1, ipAttribution=)]
    2022-11-19 医鸣惊人

    认真学习了

    0